The following paper has been selected by the Editor for FREE access to all during February and March 2011
Professor Ben Davidson has written a comprehensive review article of the differences and similarities between malignant mesothelioma and ovarian / peritoneal serous carcinoma. Davidson provides valuable insight into current research using molecular biology and flow cytometry, from which new markers will be developed, and concludes: “Cytology performs no worse than surgical pathology and has the additional advantage of being able to provide high-quality fresh material consisting of living cells for molecular analysis within both the diagnostic and research setting.”
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma (pages 5–21)
Please also read in the same issue the editorial by Professor Sheaff and an original article from Professor Davidson’s group:
Sheaff M. Should cytology be an acceptable means of diagnosing malignant mesothelioma? (editorial) Cytopathology 2011;22(1):3-4.
Yuan Y, Dong HP, Nymoen DA et al. PINCH-2 expression in cancers involving serosal effusions using quantitative PCR. Cytopathology 2011;22(1):22-9.